GIOVANNELLI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 2.753
EU - Europa 2.577
AS - Asia 1.266
SA - Sud America 198
AF - Africa 32
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.829
Nazione #
US - Stati Uniti d'America 2.707
IT - Italia 1.342
SG - Singapore 435
GB - Regno Unito 313
CN - Cina 295
IE - Irlanda 258
SE - Svezia 161
VN - Vietnam 145
HK - Hong Kong 143
BR - Brasile 140
DE - Germania 122
UA - Ucraina 71
FR - Francia 62
RU - Federazione Russa 62
FI - Finlandia 53
IN - India 44
NL - Olanda 43
TR - Turchia 33
BD - Bangladesh 32
BG - Bulgaria 24
KR - Corea 24
CA - Canada 21
ID - Indonesia 20
AR - Argentina 19
MX - Messico 19
IQ - Iraq 15
LT - Lituania 13
MY - Malesia 9
PL - Polonia 9
CO - Colombia 8
EG - Egitto 8
ES - Italia 8
IR - Iran 8
ZA - Sudafrica 8
EC - Ecuador 7
PK - Pakistan 7
VE - Venezuela 7
AL - Albania 6
CL - Cile 6
JP - Giappone 6
PH - Filippine 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
UZ - Uzbekistan 5
JO - Giordania 4
KE - Kenya 4
PT - Portogallo 4
PY - Paraguay 4
TW - Taiwan 4
UY - Uruguay 4
AT - Austria 3
AZ - Azerbaigian 3
BE - Belgio 3
CZ - Repubblica Ceca 3
IL - Israele 3
MA - Marocco 3
TH - Thailandia 3
AU - Australia 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LB - Libano 2
NG - Nigeria 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MZ - Mozambico 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SC - Seychelles 1
TJ - Tagikistan 1
TN - Tunisia 1
ZW - Zimbabwe 1
Totale 6.829
Città #
Singapore 285
Ashburn 272
Santa Clara 268
Dublin 256
Chandler 201
Southend 193
Fairfield 184
San Jose 151
Woodbridge 141
Hong Kong 139
Dearborn 134
Milan 118
Jacksonville 114
Nyköping 98
Beijing 97
Rome 97
Houston 85
Ann Arbor 84
New York 81
Seattle 70
Wilmington 66
Cambridge 62
Council Bluffs 61
London 52
Ho Chi Minh City 42
Helsinki 35
Naples 35
Hanoi 34
Los Angeles 34
Bologna 33
Bari 32
Munich 29
The Dalles 28
Hefei 25
Florence 24
Palermo 24
Izmir 22
Princeton 22
Turin 22
Eugene 21
Modena 21
Sofia 21
San Diego 20
Lauterbourg 19
Seoul 18
Dong Ket 16
Genoa 15
Jakarta 15
Shanghai 15
Moscow 14
Phoenix 13
Orem 12
Verona 12
Catania 11
São Paulo 11
Vicenza 11
Chicago 10
Denver 10
Pisa 10
Boardman 9
Bremen 9
Guangzhou 9
Padova 9
Brooklyn 8
Chennai 8
Dallas 8
Ferrara 8
Perugia 8
Redondo Beach 8
Venice 8
York 8
Atlanta 7
Brescia 7
Buffalo 7
Columbus 7
Fremont 7
Haiphong 7
San Mateo 7
Trieste 7
Ancona 6
Cagliari 6
Monte Porzio 6
Norwalk 6
Porto Alegre 6
Redwood City 6
Reggio Emilia 6
Toronto 6
Turku 6
Des Moines 5
Frankfurt am Main 5
Hải Dương 5
Lecce 5
Montreal 5
Sassari 5
Tirana 5
Tokyo 5
Warsaw 5
Augusta 4
Bergamo 4
Bitritto 4
Totale 4.312
Nome #
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 1.156
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 491
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 423
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 375
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 373
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 369
Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB) 364
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 328
A prognostic model based on nodal status and Ki 67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 311
Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial. 304
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer 266
Biomarker expression and survival after primary chemotherapy for breast cancer. 245
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 224
IMPROVED SURVIVAL AFTER RADIOTHERAPY FOR BRAIN METASTASES IN PATIENTS WITH HER2 POSITIVE BREAST TUMORS 219
Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectives 218
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 217
LAPATINIB IN ASSOCIAZIONE A CAPECITABINA IN PAZIENTI CON CARCINOMA MAMMARIO METASTTICO HER2 POSITIVO IN PROGRESSIONE DOPO TERAPIA CON TRASTUZUMAB 216
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation 200
CARCINOMI MAMMARI HER2 POSITIVI: CASISTICA DI MODENA 199
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 187
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE 167
Totale 6.852
Categoria #
all - tutte 19.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022381 8 49 53 13 7 23 20 9 50 16 88 45
2022/2023866 81 76 29 64 52 67 13 48 310 30 59 37
2023/2024766 36 45 44 48 82 68 53 111 38 69 88 84
2024/20251.328 57 65 45 129 220 193 80 96 171 66 74 132
2025/20261.925 128 67 123 228 340 132 243 97 181 237 127 22
Totale 6.852